


The Fund aims to achieve above average capital growth.
| Name | % Net Assets |
|---|---|
| Apple Inc. | 8.0% |
| Oracle Corp. | 3.8% |
| JPMorgan Chase & Co. | 3.6% |
| Wells Fargo & Co. | 3.4% |
| UnitedHealth Group Inc. | 3.0% |
| DaVita Inc. | 3.0% |
| Pfizer Inc. | 3.0% |
| Airgas Inc. | 2.9% |
| Crown Castle International Corp. | 2.5% |
| Amgen Inc. | 2.5% |
| Key | % Net Assets |
|---|---|
| 8.0% | |
| 3.8% | |
| 3.6% | |
| 3.4% | |
| 81.2% |
| Date | 09-Nov-2018 |
|---|---|
| NAV | $4.66 |
| Currency | USD |
| Change | $0.03 |
| % | 0.59% |
| YTD change | $4.66 |
| YTD % | n/a |
| Fund Inception | 31/03/1982 |
|---|---|
| Fund Manager | Cormac Weldon |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | $500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.07 |
You are here: research